ArticleCureus2026
Guillain-Barré Syndrome Presenting With Unilateral Facial Nerve Palsy: A Rare Presentation.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Guillain-Barré syndrome (GBS) is an acute immune-mediated polyradiculoneuropathy typically presenting with symmetrical ascending limb weakness and areflexia. Cranial nerve involvement is recognized, most commonly affecting the facial nerves bilaterally. Unilateral facial nerve palsy, particularly in association with severe radicular lower back pain, is an atypical presentation and may lead to diagnostic uncertainty. We report the case of a 40-year-old woman with a background of papillary thyroid cancer who presented with severe lower back pain, progressive bilateral lower limb weakness, and acute left-sided lower motor neuron facial nerve palsy following a flu-like illness with diarrheal symptoms. Initial assessment focused on stroke and malignancy recurrence. Rapid neurological deterioration with bulbar symptoms and respiratory compromise prompted further investigation. Cerebrospinal fluid analysis demonstrated albuminocytological dissociation, and nerve conduction studies confirmed GBS. The patient required intensive care admission and was treated with intravenous immunoglobulin, resulting in significant clinical improvement. This case highlights a rare and atypical presentation of GBS and emphasizes the importance of recognizing asymmetrical cranial nerve involvement to facilitate early diagnosis and timely treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.